- Number of people
- 94 643 (0.14% female)
- People with ≥2 records
- 69.25%
- Median duration from first to last measurement
- 3.87 years
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
Coding
Definition
- OMOP Concept ID
- 3001784— open in OHDSI Athena.
- Part of collection
- Prostate specific Ag.free/Prostate specific Ag.total with 0 other OMOP concept — open in OHDSI Athena.
OMOP mapping QC
OMOP concept ID | Test name | Measurement unit (harmonized unit) | N people | N records | Missing measurement value | Harmonized value distribution |
Test outcome
NA
N
A
AA
L
LL
H
HH
|
---|---|---|---|---|---|---|---|
3001784 | p-psa-suh | — (—) | 41243 | 134974 | 100.00% | Distribution not available | |
3001784 | p-psa-suh | % (%) | 27813 | 83878 | 0.01% |
|
|
3001784 | s-psa-suh | — (—) | 27044 | 77276 | 100.00% | Distribution not available | |
3001784 | psa-v/psa | — (—) | 10280 | 20616 | 100.00% | Distribution not available | |
3001784 | psa-v/psa | % (%) | 8379 | 25394 | 0.00% |
|
|
3001784 | s-psa-suh | % (%) | 6432 | 11979 | 0.00% |
|
|
3001784 | s-psa-v/t | % (%) | 4143 | 12585 | 0.00% |
|
|
3001784 | p-psa-v/t | — (—) | 1959 | 8387 | 100.00% | Distribution not available | |
3001784 | s-psa-v/t | — (—) | 1747 | 2627 | 100.00% | Distribution not available | |
3001784 | s-prostataspesifinenantigeeni,vapaa/totaali | % (%) | 1007 | 1203 | 0.00% |
|
|
3001784 | psa-vapaa/totaali-suhde,plasmasta | — (—) | 935 | 1405 | 100.00% | Distribution not available | |
3001784 | p-prostataspesifinenantigeeni,suhde | — (—) | 396 | 536 | 100.00% | Distribution not available | |
3001784 | prostataspesifinenantigeeni,vapaanosuus(vainlaboratorionkäytössä) | % (%) | 387 | 600 | 0.00% |
|
|
3001784 | s-psav/t | % (%) | 345 | 1076 | 0.00% |
|
|
3001784 | psa-v/psa-suhde | % (%) | 332 | 411 | 0.00% |
|
|
3001784 | p-prostataspesifinenantigeeni,suhde | % (%) | 326 | 437 | 0.00% |
|
|
3001784 | psa-vapaa/totaali-suhde,plasmasta | % (%) | 303 | 461 | 0.00% |
|
|
3001784 | p-psa-i | — (—) | 274 | 488 | 100.00% | Distribution not available | |
3001784 | -psa-v/t | — (—) | 209 | 436 | 100.00% | Distribution not available | |
3001784 | s-prostataspesifinenantigeeni,vapaa/kokonais-suhde | % (%) | 197 | 221 | 0.00% |
|
|
3001784 | p-psa-v/t | % (%) | 190 | 257 | 0.00% |
|
|
3001784 | s-psavapaanjatotaalinsuhde | — (—) | 123 | 166 | 100.00% | Distribution not available | |
3001784 | -psa-v/t | % (%) | 105 | 217 | 0.00% |
|
|
3001784 | p-psa-i | % (%) | 101 | 188 | 0.00% |
|
|
3001784 | psavapaanjatotaalinsuhde | — (—) | 96 | 139 | 100.00% | Distribution not available | |
3001784 | psa-v/psa-suhde | — (—) | 60 | 60 | 100.00% | Distribution not available | |
3001784 | s-psav/t | — (—) | 50 | 69 | 100.00% | Distribution not available | |
3001784 | s-psavapaanjatotaalinsuhde | % (%) | 48 | 70 | 0.00% |
|
|
3001784 | s-psa-v | % (%) | 45 | 55 | 0.00% |
|
|
3001784 | psavapaanjatotaalinsuhde | % (%) | 29 | 44 | 0.00% |
|
|
3001784 | s-psa,vapaanjatotaalinsuhde | — (—) | 26 | 30 | 100.00% | Distribution not available | |
3001784 | s-psa-v/t(pi) | % (%) | 16 | 21 | 0.00% |
|
|
3001784 | p-psa-suhd | % (%) | 13 | 15 | 0.00% | Distribution not available | |
3001784 | s-psa-suh,s-psa-v/t | % (%) | 12 | 19 | 0.00% | Distribution not available | |
3001784 | p-psa-suhd | — (—) | 12 | 14 | 100.00% | Distribution not available | |
3001784 | s-psa,vapaanjatotaalinsuhde | % (%) | 11 | 14 | 0.00% | Distribution not available | |
3001784 | !psavapaanjatotaalinsuhde | — (—) | 9 | 13 | 100.00% | Distribution not available | |
3001784 | s-psa-v/t(pi) | — (—) | 8 | 8 | 100.00% | Distribution not available | |
3001784 | s-psa-suh,s-psa-v/t | — (—) | 8 | 9 | 100.00% | Distribution not available | |
3001784 | !psavapaanjatotaalinsuhde | % (%) | 7 | 7 | 0.00% | Distribution not available | Distribution not available |
Cohort
- Number of people
- 94 643 (0.14% female)
Year of birth distribution
Age at first measurement
Age at last measurement
Age at start of registry
Duration from first to last measurement
Statistics
- People with ≥2 records
- 69.25%
- Median number of measurements per person
- 3.0
- Median duration from first to last measurement
- 3.87 years